Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

NIOSHTIC-2 Publications Search

Search Results

Studies on the biochemical basis of distal axonopathies - I. Inhibition of glycolysis by neurotoxic hexacarbon compounds.

Authors
Sabri-MI; Moore-CL; Spencer-PS
Source
J Neurochem 1979 Jan; 32(3):683-689
NIOSHTIC No.
00185862
Abstract
The effect of neurotoxic and nonneurotoxic solvents on glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) was examined. The effects were studied using both the crystalline enzyme and the endogenous enzyme present in nerve tissue. The rate of reduction of NAD in the presence of GAPDH, measured at 340 nanometers, was used to assay enzyme activity. The neurotoxic compounds 2,5-hexanedione (110134) (2,5-HD) and methyl-n-butyl-ketone (591786) (MBK) inhibited crystalline and endogenous central nervous and peripheral nervous system GAPDH when the enzyme was preincubated with the toxin. The degree of inhibition was a function of both the concentration of the toxin and the length of the incubation. The concentration of the substrate had no effect on the degree of inhibition. The enzyme activity was preserved by the addition of dithiothreitol in the presence of either neurotoxin. Lactate-dehydrogenase (LDH) activity was not inhibited by these neurotoxic chemicals. The neurologically inactive compounds, 1,6-hexanediol (629118) and acetone (67641), did not inhibit GAPDH. Studies with nerve homogenates showed that the activity of GAPDH was lowered by 2,5-HD and that LDH was not affected. In rat brain homogenates, both MBK and 2,5-HD effectively blocked GAPDH activity; MKB was more inhibitory than 2,5-HD. The results indicate that 2,5-HD and MBK block energy metabolism by inhibiting glycolysis at the site of GAPDH. These findings may account for the known failure of GAPDH dependent axonal transport and the axonal degeneration which occurs in hexacarbon neuropathy.
Keywords
NIOSH-Publication; NIOSH-Grant; Neurotoxic-effects; Organic-solvents; Biochemistry; Nervous-system-disorders; Enzyme-activity
Contact
Neuroscience Albert Einstein College 1410 Pelham Parkway Bronx, N Y 10461
CODEN
JONRA9
CAS No.
110-13-4; 591-78-6; 629-11-8; 67-64-1
Publication Date
19790101
Document Type
Journal Article
Funding Amount
912712
Funding Type
Grant
Fiscal Year
1979
NTIS Accession No.
NTIS Price
Identifying No.
Grant-Number-R01-OH-00851
Issue of Publication
3
ISSN
0022-3042
Priority Area
Neurotoxic-effects
Source Name
Journal of Neurochemistry
State
NY
Performing Organization
Yeshiva University, New York, New York
TOP